BFFAF BASF SE Earnings Preview April 30, 2026

BASF SE (BFFAF) reports earnings on April 30, 2026, with analysts expecting $1.25 earnings per share and $18.27 billion in revenue. The German chemical giant operates across six segments including chemicals, materials, and agricultural solutions. With a market cap of $57.25 billion and current stock price of $64.64, BFFAF trades at a 34.38 PE ratio. Recent earnings history shows mixed results, with the company beating revenue estimates but missing EPS expectations in recent quarters. Investors will focus on operational efficiency and segment performance as the chemical industry faces ongoing headwinds.

Earnings Estimates and Historical Performance

Analysts project BASF will deliver $1.25 EPS and $18.27 billion in revenue for the upcoming quarter. This represents a significant jump from the previous quarter’s $0.2144 EPS estimate, though actual results showed $0.733 EPS. Revenue estimates of $18.27 billion exceed the prior quarter’s $14.73 billion estimate.

Recent Earnings Trend

BASF’s earnings history reveals volatility. The most recent quarter (February 2026) saw actual EPS of $0.733 against a $0.2144 estimate, a substantial beat. However, the October 2025 quarter showed $0.558 actual EPS versus $0.3513 estimate. Revenue performance has been stronger, with actual results consistently exceeding estimates. The July 2025 quarter delivered $18.57 billion in revenue against a $15.22 billion estimate.

Beat or Miss Prediction

Based on historical patterns, BASF shows a mixed track record. The company has beaten revenue estimates in four consecutive quarters, suggesting strong operational execution. However, EPS estimates have been less predictable. Given the current $1.25 EPS estimate is substantially higher than recent quarters, investors should expect potential volatility. The company’s ability to manage costs and maintain margins will determine whether it meets this elevated expectation.

Key Metrics and Valuation Context

BASF trades at a 34.38 PE ratio with a current price of $64.64, up 1.17% today. The stock has gained 24.09% year-to-date and 29.93% over six months, reflecting investor optimism about the chemical sector recovery.

Financial Health Indicators

The company maintains a current ratio of 1.93, indicating solid short-term liquidity. Debt-to-equity stands at 0.74, which is manageable for a capital-intensive chemical manufacturer. Free cash flow per share of $1.51 shows the company generates cash despite capital requirements. Return on equity of 4.82% reflects the capital-intensive nature of chemical production.

Segment Performance Watch

Investors should monitor performance across BASF’s six segments. The Materials segment, which includes advanced polymers and isocyanates, faces cyclical demand. Agricultural Solutions performance depends on crop prices and farmer spending. Surface Technologies benefits from automotive production trends. The Nutrition & Care segment provides defensive characteristics with steady demand from food and pharmaceutical customers.

What to Watch During the Earnings Call

Management guidance on chemical demand trends will be critical. BASF operates globally, so commentary on European economic conditions, Chinese industrial activity, and North American manufacturing will shape investor sentiment.

Operational Efficiency Focus

Analysts will scrutinize gross margins, which currently stand at 24.86%. Operating margins of 4.08% are thin for the industry, reflecting competitive pressures. Management should address cost control initiatives and pricing power in key markets. The company’s R&D spending of 3.31% of revenue supports innovation but requires justification through product launches and market share gains.

Capital Allocation Strategy

Dividend sustainability matters to income investors. BASF pays $2.18 per share annually with a 3.95% yield. The payout ratio of 131.55% exceeds earnings, raising questions about dividend coverage. Management must clarify how they balance shareholder returns with debt reduction and growth investments. Free cash flow growth of 79.55% year-over-year is encouraging and may support dividend stability.

Meyka AI Grade and Investment Perspective

Meyka AI rates BFFAF with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Grade Components Breakdown

The B rating reflects neutral positioning. BASF scores well on return on assets (5.0 strong buy rating) and price-to-book valuation (4.0 buy rating). However, the debt-to-equity ratio receives a 1.0 strong sell rating, indicating leverage concerns. The PE ratio of 34.38 generates a 2.0 sell rating, suggesting the stock may be fairly valued or slightly expensive relative to earnings.

Sector Context

BASF operates in the Basic Materials sector, which has recovered from pandemic lows but faces structural challenges. Chemical companies typically trade at lower multiples than technology or healthcare firms. The 34.38 PE ratio is elevated for the sector, reflecting market expectations for earnings growth. Investors should compare BFFAF valuation to peers like Dow Inc. and Lyondell Basell to assess relative value.

Final Thoughts

BASF SE’s April 30 earnings will test whether the chemical giant can sustain recent momentum. Analysts expect $1.25 EPS and $18.27 billion revenue, representing significant growth from recent quarters. The company’s consistent revenue beat record is encouraging, though EPS volatility warrants caution. With a B grade from Meyka AI and a 34.38 PE ratio, BFFAF appears fairly valued but not cheap. Investors should focus on segment performance, margin trends, and management’s outlook for chemical demand. The 3.95% dividend yield attracts income investors, but dividend coverage concerns require clarification. Overall, BFFAF represents a stable chemical play for diversified portfolios, though gr…

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.